Es in antibody-associated central nervous system pathologies. Rev Neurol (Paris). 2014;170:587?4. 36. Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol. 1999;46:263?.37. Lauria G, Pareyson D, Pitzolu G, Bazzigaluppi E. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol. 2003;2:634?. 38. Birand B, Cabre P, Bonnan M, Olindo S, Smadja D. A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative. Rev Med Interne. 2006;27:616?. 39. McFarland NR, Login IS, Verno S, Burns TM. Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia. Neurology. 2006;67:1308?. 40. Kim JY, Chung EJ, Kim JH, Jung KY, Lee WY. ReVaninsponse to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff-person syndrome and polyendocrinopathy. Mov Disord. 2006;21:2263?2. 41. Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry. 2007;78:187?. 42. Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg. 2007;109:54?. 43. Bonnan M, Cabre P, Olindo S, Signate A, Saint-Vil M, Smadja D. Steroid treatment in four cases of anti-GAD cerebellar ataxia. Rev Neurol. 2008;164:427?3. 44. Abele M, Weller M, Mescheriakov S, B k K, Dichgans J, Klockgether T. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology. 1999;52:857?. 45. Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song SY, Harigaya Y, Igeta Y, et al. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2001;70:386?9. 46. R gg S, Stahl M, B lmann M, Dupont A, Lyrer PA, Humbel RL, et al. Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies. J Neurol. 2002;249:348?0. 47. Matsumoto S, Kusuhara T, Nakajima M, Ouma S, Takahashi M, Yamada T. Acute attacks and brain stem signs in a patient with glutamic acid decarboxylase autoantibodies. J Neurol Neurosurg Psychiatry. 2002;73:343?0. 48. Georgieva Z, Parton Nelfinavir (Mesylate) M. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis. BMJ Case Rep. 2014. doi:10.1136/bcr-2013-202314. 49. Planche V, Marques A, Ulla M, Ruivard M, Durif F. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Cerebellum. 2014;13:318?2. 50. Kuchling J, Shababi-Klein J, N ann A, Gerischer LM, Harms L, Pr s H. GAD antibody-associated late-onset cerebellar ataxia in two female siblings. Case Rep Neurol. 2014;6:264?0. 51. Ario H, Gresa-Arribas N, Blanco Y, Mart ez-Hern dez E, Sabater L, PetitPedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies. Immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009?6. 52. Nanri K, Niwa H, Mitoma H, Takei A, Ikeda J, Harada T, et al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum. 2013;12:171?. 53. Virgilio R, Corti S, Agazzi P, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/7500280 Santoro D, Lanfranconi S, Candelise L, et al. Effect of steroid treatment in cerebellar at.